Clinical trialNCT00499967CompletedPhase 1Interventional

Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts

SponsorGilead SciencesEnrollment202Genital Warts

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to assess the safety, tolerability and activity of GS-9191 ointment in the treatment of genital warts. GS-9191 ointment is intended for topical application directly to genital warts on the skin.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Elsa Mondou, MD
Gilead Sciences
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Facility name not stated
Tucson, Arizona, United States
Facility name not stated
Beverly Hills, California, United States
Facility name not stated
Mission Viejo, California, United States
Facility name not stated
San Francisco, California, United States
Facility name not stated
San Francisco, California, United States
Facility name not stated
Santa Rosa, California, United States
Facility name not stated
Vallejo, California, United States
Facility name not stated
Orlando, Florida, United States
Facility name not stated
Tampa, Florida, United States
Facility name not stated
Indianapolis, Indiana, United States
Facility name not stated
St Louis, Missouri, United States
Facility name not stated
Las Vegas, Nevada, United States
Facility name not stated
New York, New York, United States
Facility name not stated
Stony Brook, New York, United States
Facility name not stated
Raleigh, North Carolina, United States
Facility name not stated
Tulsa, Oklahoma, United States
Facility name not stated
Portland, Oregon, United States
Facility name not stated
Greenville, South Carolina, United States
Facility name not stated
Chattanooga, Tennessee, United States
Facility name not stated
Dallas, Texas, United States
Facility name not stated
Houston, Texas, United States
Facility name not stated
San Antonio, Texas, United States
Facility name not stated
San Antonio, Texas, United States
Facility name not stated
Salt Lake City, Utah, United States
Facility name not stated
Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

GS-9191GS-9191 ointmentPlacebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Aug 2007
Primary completion: 28 Feb 2009
Completion: 31 Mar 2009
Last update posted: 9 Apr 2009
Registered enrollment: 202
Registry id: NCT00499967

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.